Plus Therapeutics Inc (PSTV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2012 | 03-2012 | 12-2011 | 09-2011 | 06-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 25,771 | 34,399 | 36,922 | 40,803 | 33,229 |
| Receivables | 1,983 | 1,425 | 2,260 | 1,967 | 2,461 |
| Inventories | 3,108 | 3,374 | 3,318 | 4,153 | 3,891 |
| Other current assets | 1,115 | 1,135 | 837 | 702 | 849 |
| TOTAL | $31,977 | $40,333 | $43,337 | $47,625 | $40,430 |
| Non-Current Assets | |||||
| PPE Net | 2,255 | 2,367 | 1,711 | 1,788 | 1,923 |
| Investments And Advances | 164 | 200 | 250 | 306 | 357 |
| Intangibles | 4,003 | 4,058 | 4,114 | 4,169 | 4,225 |
| Other Non-Current Assets | 2,105 | 2,144 | 2,122 | 1,680 | 1,821 |
| TOTAL | $8,527 | $8,769 | $8,197 | $7,943 | $8,326 |
| Total Assets | $40,504 | $49,102 | $51,534 | $55,568 | $48,756 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 7,338 | 4,911 | 2,487 | 69 | 8,755 |
| Accounts payable and accrued liabilities | 5,066 | 6,046 | 5,334 | 6,374 | 6,857 |
| TOTAL | $12,404 | $10,957 | $7,821 | $6,443 | $15,612 |
| Non-Current Liabilities | |||||
| Long Term Debt | 17,441 | 19,704 | 21,962 | 24,209 | 9,295 |
| Other Non-Current Liabilities | 3,108 | 2,397 | 2,537 | 3,123 | 4,089 |
| TOTAL | $27,552 | $31,295 | $33,767 | $37,199 | $23,003 |
| Total Liabilities | $39,956 | $42,252 | $41,588 | $43,642 | $38,615 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 58,711 | 58,686 | 57,929 | 55,335 | 53,796 |
| Common Shares | 59 | 58 | 57 | 55 | 52 |
| Retained earnings | -259,657 | -251,774 | -242,449 | -235,542 | -227,207 |
| TOTAL | $548 | $6,850 | $9,946 | $11,926 | $10,141 |
| Total Liabilities And Equity | $40,504 | $49,102 | $51,534 | $55,568 | $48,756 |